Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Plant Allergenic Extract [EPC]
Eucalyptus Gum is a non-standardized plant allergenic extract used primarily in the diagnosis and treatment of specific allergies. It belongs to the class of plant-based allergenic extracts used in immunotherapy.
Name
Eucalyptus Gum
Raw Name
EUCALYPTUS GUM
Category
Non-Standardized Plant Allergenic Extract [EPC]
Drug Count
4
Variant Count
6
Last Verified
February 17, 2026
About Eucalyptus Gum
Eucalyptus Gum is a non-standardized plant allergenic extract used primarily in the diagnosis and treatment of specific allergies. It belongs to the class of plant-based allergenic extracts used in immunotherapy.
Detailed information about Eucalyptus Gum
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Eucalyptus Gum.
Eucalyptus Gum belongs to a class of drugs called allergenic extracts. These substances are designed to interact with the human immune system to either diagnose sensitivity to eucalyptus pollens/botanicals or to induce immunological tolerance through a process known as allergen immunotherapy (AIT). While Eucalyptus Gum is often associated with traditional herbal medicine, its clinical application in modern medicine is strictly regulated by the FDA under the category of biological products. The FDA approval history for non-standardized extracts like Eucalyptus Gum dates back decades, with many being grandfathered into the current regulatory framework based on long-standing clinical use for diagnostic skin testing and subcutaneous immunotherapy (SCIT).
The mechanism of action for Eucalyptus Gum depends on its clinical application. When used for diagnostic purposes, such as in a skin prick test, the extract is introduced into the epidermis. If the patient has pre-existing IgE (Immunoglobulin E) antibodies specific to eucalyptus allergens, these antibodies, which are bound to mast cells in the skin, will recognize the proteins in the Eucalyptus Gum. This recognition triggers mast cell degranulation, releasing histamine and other inflammatory mediators, resulting in a 'wheal and flare' reaction (a raised bump and redness). This serves as a clinical marker for Type I hypersensitivity.
When used therapeutically in immunotherapy, the mechanism is more complex and involves 'desensitization.' By administering gradually increasing doses of the Eucalyptus Gum extract, the healthcare provider aims to shift the patient's immune response. At the molecular level, this involves:
As a biological extract administered primarily through subcutaneous (under the skin) injection, Eucalyptus Gum does not follow the traditional ADME (Absorption, Distribution, Metabolism, and Elimination) pathways of small-molecule drugs like aspirin or ibuprofen.
Eucalyptus Gum is primarily indicated for:
Off-label uses are rare but may include research into the extract's potential effects on the adrenal cortex, given its secondary classification as an Adrenocorticotropic Hormone [EPC] in some pharmacological databases, though this is not a standard clinical practice in 2026.
Eucalyptus Gum is typically available in the following forms:
> Important: Only your healthcare provider can determine if Eucalyptus Gum is right for your specific condition. Immunotherapy should only be conducted under the supervision of a board-certified allergist or immunologist.
Dosage for Eucalyptus Gum is highly individualized and must be determined by an allergy specialist through a 'dose-titration' process. There is no standard 'one-size-fits-all' dose for non-standardized extracts.
Eucalyptus Gum extracts are generally considered safe for use in children, typically starting around age 5, depending on the child's ability to cooperate with the injection schedule and report symptoms. Dosing follows the same escalation and maintenance logic as adult dosing, though the starting concentration may be even more conservative based on the child's sensitivity levels.
No specific dosage adjustments are typically required for patients with kidney disease, as the extract is a biological protein mixture. However, the patient's overall health must be stable before administration.
No dosage adjustments are defined for liver impairment. The metabolic clearance of these proteins is not dependent on hepatic CYP450 enzymes.
Caution is advised in elderly patients, particularly those with underlying cardiovascular disease. The risk of being unable to tolerate a systemic reaction (anaphylaxis) or the epinephrine used to treat it must be weighed against the benefits of immunotherapy.
Eucalyptus Gum extracts are strictly for professional administration. They are given via subcutaneous injection, usually in the outer aspect of the upper arm.
If a dose is missed during the escalation phase, the next dose may need to be reduced to ensure safety. If a dose is missed during the maintenance phase, the healthcare provider will determine if the dose needs to be adjusted based on how much time has passed since the last injection. Never attempt to 'double up' on doses at home.
An 'overdose' in the context of Eucalyptus Gum refers to an injection that exceeds the patient's current tolerance level. This can lead to a systemic allergic reaction or anaphylaxis.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or schedule without medical guidance.
Most patients receiving Eucalyptus Gum immunotherapy will experience local reactions. These are generally not dangerous but can be uncomfortable.
These reactions are more widespread than the local site but are not necessarily life-threatening.
> Warning: Stop receiving Eucalyptus Gum injections and call your doctor immediately or seek emergency care if you experience any of these symptoms of anaphylaxis.
The long-term goal of Eucalyptus Gum use is to induce permanent immunological tolerance. In some cases, patients may develop a persistent sensitivity, or their allergy symptoms may return after the treatment is discontinued. There is no evidence that long-term use of allergenic extracts causes organ damage or cancer.
Allergenic extracts, including Eucalyptus Gum, carry a standard FDA-required warning regarding the risk of severe systemic reactions.
Summary of Warning: Eucalyptus Gum can cause life-threatening allergic reactions, including anaphylaxis. Because of this risk, Eucalyptus Gum should only be administered in a healthcare setting by personnel prepared to treat anaphylaxis. Patients with unstable asthma are at higher risk for severe reactions. Patients must be observed for at least 30 minutes following administration.
Report any unusual symptoms, even if they seem mild, to your healthcare provider immediately.
Eucalyptus Gum is a potent biological substance. It is not a 'natural supplement' in the context of its clinical use; it is an active immunological agent. Patients must be transparent with their allergist regarding their current health status before every single injection. If you are feeling ill, have a fever, or are experiencing an asthma flare-up, the injection must be postponed.
No FDA black box warnings for Eucalyptus Gum specifically, but it falls under the general class warning for all allergenic extracts regarding anaphylaxis. The warning emphasizes that these products are not for self-administration and require professional supervision due to the risk of sudden, severe systemic allergic reactions.
Eucalyptus Gum does not typically cause sedation. However, if you experience a systemic reaction or feel lightheaded after an injection, you should not drive or operate machinery until you have fully recovered and been cleared by a medical professional.
Alcohol should be avoided on the day of the injection. Alcohol can dilate blood vessels and increase the rate of allergen absorption, potentially increasing the risk of a systemic reaction.
Immunotherapy is a long-term commitment (usually 3 to 5 years). Stopping the treatment prematurely may result in the return of allergy symptoms. There is no 'withdrawal syndrome' associated with stopping Eucalyptus Gum, as it is not an addictive substance, but the 'tapering' refers to the gradual increase of doses at the beginning, not the end of therapy.
> Important: Discuss all your medical conditions, especially respiratory or heart issues, with your healthcare provider before starting Eucalyptus Gum.
For each major interaction, the mechanism usually involves either a pharmacodynamic interaction (where the drugs have opposing or synergistic effects on the body's systems, like beta-blockers and epinephrine) or an immunological interference (where a drug like a steroid changes how the immune system processes the allergen).
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter cold medicines.
Eucalyptus Gum must NEVER be used in the following circumstances:
Conditions requiring careful risk-benefit analysis include:
Patients who are allergic to other members of the Myrtaceae family (such as Myrtle, Allspice, or Clove) may show cross-sensitivity to Eucalyptus Gum. A thorough history of botanical allergies is essential before the first dose.
> Important: Your healthcare provider will evaluate your complete medical history, including your lung function and heart health, before prescribing Eucalyptus Gum.
Eucalyptus Gum is generally classified as Pregnancy Category C. This means there are no adequate, well-controlled studies in pregnant women. The primary risk during pregnancy is not the extract itself, but the potential for a systemic allergic reaction (anaphylaxis) in the mother. Anaphylaxis can lead to a sudden drop in maternal blood pressure, significantly reducing blood flow to the placenta and potentially causing fetal distress or death.
Clinical Practice: It is standard practice to NOT initiate Eucalyptus Gum escalation during pregnancy. If a patient reaches a maintenance dose and then becomes pregnant, the physician may choose to continue the maintenance dose or reduce it, but they will rarely increase it.
It is not known whether the components of Eucalyptus Gum are excreted in human milk. However, since the extract consists of large proteins that are processed locally in the mother's lymphatic system, it is highly unlikely that significant amounts would reach the breast milk or be absorbed by the nursing infant's digestive tract. The risk-benefit profile is generally favorable for continuing treatment while breastfeeding.
Eucalyptus Gum is approved for use in children who have been diagnosed with specific eucalyptus allergies. The main considerations for pediatric use are the child's emotional maturity to handle frequent injections and their ability to describe symptoms like 'itchy throat' or 'tight chest.' There is no evidence that Eucalyptus Gum immunotherapy affects growth or development in children.
In patients over 65, the decision to use Eucalyptus Gum must be made with caution. Older adults are more likely to have co-morbidities like coronary artery disease or COPD, which make them more vulnerable to the complications of an allergic reaction. Furthermore, the use of multiple medications (polypharmacy) in the elderly increases the risk of drug interactions with the emergency medications used to treat anaphylaxis.
No dosage adjustments are required for patients with renal impairment. The proteins in Eucalyptus Gum are naturally degraded into amino acids and do not pose a known risk of nephrotoxicity (kidney damage).
There are no specific guidelines for Eucalyptus Gum use in patients with liver disease. Since the extract is not metabolized by the liver's cytochrome P450 system, hepatic impairment does not significantly alter the pharmacokinetics of the allergenic proteins.
> Important: Special populations require individualized medical assessment and often more frequent monitoring during the escalation phase of therapy.
Eucalyptus Gum acts as an immunomodulator. Its primary molecular targets are the IgE antibodies and the T-lymphocytes. In an allergic individual, B-cells produce high levels of IgE specific to eucalyptus proteins. These IgE molecules coat the surface of mast cells and basophils.
Upon administration of the extract, the following occurs:
The pharmacodynamic effect is measured by the reduction in the 'wheal and flare' response during skin testing and the reduction of clinical symptoms (sneezing, wheezing) upon environmental exposure. The onset of effect is slow, often taking 3 to 6 months to notice a difference, with maximum benefit occurring after 1 to 2 years of continuous treatment.
| Parameter | Value |
|---|---|
| Bioavailability | Localized subcutaneous absorption; systemic bioavailability is not applicable for proteins |
| Protein Binding | Minimal systemic protein binding; interacts with cell-bound IgE |
| Half-life | Variable (hours for individual proteins; weeks for immunological effect) |
| Tmax | 30 minutes to 2 hours for local tissue concentration |
| Metabolism | Local proteolytic degradation |
| Excretion | Renal (as metabolites/amino acids) |
Eucalyptus Gum extract is a complex mixture. The primary active components are glycoproteins and proteins with molecular weights typically ranging from 10 to 70 kDa. It is soluble in aqueous buffers and is usually stabilized with 50% glycerin for skin testing or phenol for multi-dose injection vials. The molecular formula is not applicable as it is a biological mixture of various macromolecules.
Eucalyptus Gum is classified as a Non-Standardized Plant Allergenic Extract. It shares this class with other botanical extracts like Oak, Pine, and various grass pollens. It is distinct from 'standardized' extracts like Ragweed or Dust Mite, which have federally mandated potency requirements.
Common questions about Eucalyptus Gum
Eucalyptus Gum is primarily used in the field of allergy and immunology for two purposes: diagnosing and treating allergies to eucalyptus. For diagnosis, it is used in skin prick tests where a small amount is applied to the skin to see if a reaction occurs. For treatment, it is used in allergen immunotherapy, commonly known as 'allergy shots.' This involves giving small, increasing doses of the extract to help the immune system build up a tolerance to the allergen. Over time, this can significantly reduce symptoms like sneezing, itchy eyes, and asthma triggered by eucalyptus. It is not used as a general cough suppressant or topical rub in this clinical form.
The most common side effects are localized to the site of the injection. Most patients will experience some degree of redness, swelling, and itching at the injection site, which usually appears within minutes and fades within a few hours. These are known as 'local reactions' and are generally considered a normal part of the body's response to the extract. Some patients may also experience a 'late-phase' local reaction where the swelling returns or persists for 24 to 48 hours. While these are uncomfortable, they are not usually dangerous. However, any local reaction larger than the size of a palm should be reported to your doctor, as it may require a dosage adjustment for your next shot.
It is strongly recommended that you avoid consuming alcohol on the days you receive a Eucalyptus Gum injection. Alcohol can cause vasodilation, which is the widening of blood vessels. This increased blood flow can cause the eucalyptus allergens to be absorbed into your bloodstream more quickly than intended, which significantly increases the risk of a systemic allergic reaction or anaphylaxis. Furthermore, alcohol can impair your ability to recognize early warning signs of an allergic reaction, such as lightheadedness or a racing heart. To ensure maximum safety, wait at least 24 hours after your injection before consuming alcoholic beverages.
The safety of starting Eucalyptus Gum immunotherapy during pregnancy has not been established, and it is generally avoided. The main concern is not that the gum itself causes birth defects, but that a severe allergic reaction (anaphylaxis) in the mother could deprive the developing fetus of oxygen. Because of this risk, allergists almost never start the 'build-up' phase of shots for a pregnant patient. However, if a woman is already on a stable maintenance dose and becomes pregnant, her doctor may decide to continue the shots at the same or a reduced dose. Always inform your allergist immediately if you become pregnant or are planning to become pregnant.
Allergen immunotherapy with Eucalyptus Gum is a slow process and requires patience. Most patients do not see a significant improvement in their allergy symptoms during the initial 'build-up' phase, which lasts 3 to 6 months. Typically, noticeable relief begins during the first year of maintenance therapy. For the best results and long-lasting protection, the treatment is usually continued for a total of 3 to 5 years. If there is no significant improvement after one year of maintenance-level doses, your healthcare provider may re-evaluate the treatment plan or test for other underlying allergies.
Yes, you can stop taking Eucalyptus Gum injections suddenly without experiencing physical withdrawal symptoms like those associated with narcotics or antidepressants. However, stopping the treatment before the recommended 3-to-5-year course is finished likely means your allergy symptoms will eventually return. The immune system requires a long period of exposure to the extract to 'learn' permanent tolerance. If you need to stop treatment due to side effects, financial reasons, or a move, discuss it with your allergist first. They can provide guidance on how to manage your allergies using other medications like antihistamines or nasal sprays.
If you miss a scheduled injection of Eucalyptus Gum, contact your allergist's office as soon as possible to reschedule. Do not attempt to make up for the missed dose by taking a higher dose later. The safety of immunotherapy depends on a consistent schedule. If too much time passes between doses (usually more than a few weeks), your immune system's sensitivity may increase, making your previous dose level potentially unsafe. Depending on how many weeks have been missed, your doctor may need to reduce your next dose and then gradually build it back up to ensure you do not have a systemic reaction.
There is no clinical evidence to suggest that Eucalyptus Gum allergenic extracts cause weight gain. Unlike systemic corticosteroids (like prednisone), which are known to affect metabolism and appetite, Eucalyptus Gum is a biological protein extract that works specifically on the immune system's response to allergens. It does not contain hormones or calories that would contribute to weight changes. If you experience weight gain while undergoing immunotherapy, it is likely due to other factors, such as lifestyle changes or other medications you may be taking, and you should discuss this with your primary care physician.
Eucalyptus Gum can be taken with many medications, but there are some critical exceptions. The most important medications to avoid are beta-blockers, often used for heart conditions or high blood pressure, because they can make an allergic reaction much harder to treat. You should also be cautious with ACE inhibitors and MAOIs. Most standard allergy medications, like antihistamines and nasal steroids, are safe to use and are often continued during the early stages of immunotherapy. Always provide your allergist with a complete and updated list of every medication, supplement, and herbal remedy you are taking to prevent dangerous interactions.
The concept of 'generic' vs. 'brand name' is different for allergenic extracts like Eucalyptus Gum than for standard pills. Eucalyptus Gum is a biological product, and various manufacturers produce their own versions of the extract. While they all contain proteins from the *Eucalyptus globulus* tree, they are 'non-standardized,' meaning the exact concentration of specific proteins can vary between different manufacturers. Therefore, you cannot easily 'swap' one manufacturer's extract for another mid-treatment. Your allergist will typically stick with one reliable supplier for your specific treatment vial to ensure consistency and safety throughout your immunotherapy course.